my account log out | |
Anti-Ccnd1 immunotoxin (IgG)-RTA |
Create: 02/27/2017 |
Expired Date: | 02/16/2021 |
Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
Message: | This immunotoxin was achieved by conjugating/fusing the Anti-Ccnd1 monoclonal antibody to ricin toxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to B cell tumor cells. Then the ricin A chain is incorporated into the cell by receptor-mediated endocytosis, blocking ribosomal protein synthesis and ultimately leading to cell death. It was designed for treatment of B cell tumor. |
City: | Shirley[US] |
Location: | |
Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 214 | |
Feb 01 2023 | GVBE Buffer | 214 | |
Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 208 | |
Aug 30 2019 | Anti-HSV-2 gH Antibody | 393 | |
Aug 30 2019 | Anti-L. major LPG Antibody | 476 | |
Aug 30 2019 | Anti-DENV-1 Antibody | 385 | |
Aug 30 2019 | Anti-BPV-1 L1 Antibody | 401 | |
Aug 30 2019 | Anti-H3N2 HA Antibody | 387 | |
Aug 30 2019 | Anti-EIAV env Antibody | 411 |
Copyright © toextrade Inc. All rights reserved. Contact us |